PCN195 COST COMPARISON BETWEEN LEUPROLIDE 3-MONTH FORMULATION AND GOSERELIN 1-MONTH FORMULATION AS ADJUVANT ENDOCRINE THERAPY IN POST-MASTECTOMY, PREMENOPAUSAL WOMEN WITH EARLY-STAGE, ESTROGEN RECEPTOR-POSITIVE BREAST CANCER WHO ARE AT MODE ...
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.391
https://www.valueinhealthjournal.com/article/S1098-3015(19)32769-X/fulltext
Title :
PCN195 COST COMPARISON BETWEEN LEUPROLIDE 3-MONTH FORMULATION AND GOSERELIN 1-MONTH FORMULATION AS ADJUVANT ENDOCRINE THERAPY IN POST-MASTECTOMY, PREMENOPAUSAL WOMEN WITH EARLY-STAGE, ESTROGEN RECEPTOR-POSITIVE BREAST CANCER WHO ARE AT MODE ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32769-X&doi=10.1016/j.jval.2019.09.391
First page :
Section Title :
Open access? :
No
Section Order :
10321